TW347386B - N-substituted β-aryl- and β-heteroaryl-α-cyanoacrylamide derivatives - Google Patents

N-substituted β-aryl- and β-heteroaryl-α-cyanoacrylamide derivatives

Info

Publication number
TW347386B
TW347386B TW084102825A TW84102825A TW347386B TW 347386 B TW347386 B TW 347386B TW 084102825 A TW084102825 A TW 084102825A TW 84102825 A TW84102825 A TW 84102825A TW 347386 B TW347386 B TW 347386B
Authority
TW
Taiwan
Prior art keywords
heteroaryl
aryl
substituted
hydrogen
cyanoacrylamide
Prior art date
Application number
TW084102825A
Other languages
English (en)
Inventor
Buzzetti Franco
Crugnoila Angelo
Longo Antonio
Maria Brasca Gabriella
Ballinari Dario
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Application granted granted Critical
Publication of TW347386B publication Critical patent/TW347386B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW084102825A 1994-03-28 1995-03-23 N-substituted β-aryl- and β-heteroaryl-α-cyanoacrylamide derivatives TW347386B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9406137A GB9406137D0 (en) 1994-03-28 1994-03-28 N-substituted beta-aryl- and betaheteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
TW347386B true TW347386B (en) 1998-12-11

Family

ID=10752648

Family Applications (1)

Application Number Title Priority Date Filing Date
TW084102825A TW347386B (en) 1994-03-28 1995-03-23 N-substituted β-aryl- and β-heteroaryl-α-cyanoacrylamide derivatives

Country Status (21)

Country Link
US (1) US5652250A (zh)
EP (1) EP0700388B1 (zh)
JP (1) JPH08511562A (zh)
KR (1) KR960702442A (zh)
CN (1) CN1125942A (zh)
AT (1) ATE224371T1 (zh)
AU (1) AU685599B2 (zh)
DE (1) DE69528229T2 (zh)
ES (1) ES2183866T3 (zh)
FI (1) FI955661A (zh)
GB (1) GB9406137D0 (zh)
HU (1) HUT73811A (zh)
IL (1) IL113044A0 (zh)
MX (1) MX9504895A (zh)
MY (1) MY130160A (zh)
NO (1) NO954692L (zh)
NZ (1) NZ281630A (zh)
PL (1) PL311745A1 (zh)
TW (1) TW347386B (zh)
WO (1) WO1995026341A1 (zh)
ZA (1) ZA952423B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9613021D0 (en) * 1996-06-21 1996-08-28 Pharmacia Spa Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
WO1997049653A2 (en) * 1996-06-24 1997-12-31 Irori Solid phase tyrphostin library linked to matrices with memories
EP1060160A2 (en) 1998-02-27 2000-12-20 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
HUP0000920A3 (en) * 2000-02-28 2002-03-28 Sanofi Synthelabo Pde4 inhibitor isoquinolinylidene derivatives, process for their preparation and medicaments containing them
EP1752446A3 (en) * 2000-04-13 2007-03-21 HSC Research and Development Limited Partnership Compounds for modulating cell proliferation
BR0110087A (pt) * 2000-04-13 2004-02-17 Hsc Res Dev Lp Compostos para modular proliferação celular
US20050014690A1 (en) * 2001-10-11 2005-01-20 Chaim Roifman Styryl acrylonitrile compounds and their use to promote myelopoiesis
SI1701941T1 (sl) * 2003-12-11 2012-09-28 Univ Texas Spojine za zdravljenje celičnih proliferativnih bolezni
CA2560584A1 (en) 2004-03-26 2005-10-06 Hsc Research And Development Limited Partnership Novel compounds for modulating cell proliferation
US20100292229A1 (en) * 2006-06-30 2010-11-18 The Board Of Regents Of The University Of Texas System Tryphostin-analogs for the treatment of cell proliferative diseases
JP5675606B2 (ja) 2008-07-08 2015-02-25 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム シグナル伝達性転写因子（ｓｔａｔ）の増殖及び活性化の新規の抑制剤
AU2010319964A1 (en) 2009-11-16 2012-06-07 The Regents Of The University Of California Kinase inhibitors
CN103459371A (zh) * 2011-04-02 2013-12-18 中国人民解放军军事医学科学院毒物药物研究所 芳基丙烯酰胺化合物及其用于制备免疫抑制剂的用途
AU2012255759B2 (en) * 2011-05-17 2017-08-10 Principia Biopharma, Inc. Kinase inhibitors
CA2860022A1 (fr) * 2011-12-30 2013-07-04 Universite D'auvergne Clermont I Composes anti-douleur
JP2016537316A (ja) * 2013-10-10 2016-12-01 ザ リージェンツ オブ ザ ユニバーシティー オブ ミシガン デユビキチナーゼ阻害剤およびその使用方法
CN108276366B (zh) * 2018-01-08 2021-09-03 四川大学 一种丙烯酰胺类衍生物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000950D0 (en) * 1990-01-16 1990-03-14 Erba Carlo Spa New arylvinylamide derivatives and process for their preparation
GB9000939D0 (en) * 1990-01-16 1990-03-14 Erba Carlo Spa Improvement in the total synthesis of erbstatin analogs
GB9004483D0 (en) * 1990-02-28 1990-04-25 Erba Carlo Spa New aryl-and heteroarylethenylene derivatives and process for their preparation
JPH05507072A (ja) * 1990-04-16 1993-10-14 イッスム　リサーチ　ディヴェロプメント　カンパニー　オブ　ザ　ヒーブルー　ユニヴァーシティ　オブ　エルサレム Ｅｇｆレセプタチロシンキナーゼを阻害する複素環式エテンジイル化合物
US5196446A (en) * 1990-04-16 1993-03-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Certain indole compounds which inhibit EGF receptor tyrosine kinase
GB9115160D0 (en) * 1991-07-12 1991-08-28 Erba Carlo Spa Methylen-oxindole derivatives and process for their preparation
CA2080554A1 (en) * 1991-10-15 1993-04-16 Mitsubishi Chemical Corporation Styrene derivatives
GB9204945D0 (en) * 1992-03-06 1992-04-22 Erba Carlo Spa 3-aryl-glycidic ester derivatives and process for their preparation
GB9226855D0 (en) * 1992-12-23 1993-02-17 Erba Carlo Spa Vinylene-azaindole derivatives and process for their preparation

Also Published As

Publication number Publication date
CN1125942A (zh) 1996-07-03
DE69528229T2 (de) 2003-08-14
MX9504895A (es) 1998-03-31
DE69528229D1 (en) 2002-10-24
PL311745A1 (en) 1996-03-18
IL113044A0 (en) 1995-06-29
EP0700388A1 (en) 1996-03-13
NZ281630A (en) 1998-02-26
AU685599B2 (en) 1998-01-22
WO1995026341A1 (en) 1995-10-05
ES2183866T3 (es) 2003-04-01
HUT73811A (en) 1996-09-30
NO954692D0 (no) 1995-11-20
GB9406137D0 (en) 1994-05-18
FI955661A (fi) 1996-01-19
ZA952423B (en) 1995-12-19
FI955661A0 (fi) 1995-11-24
US5652250A (en) 1997-07-29
ATE224371T1 (de) 2002-10-15
HU9503714D0 (en) 1996-02-28
MY130160A (en) 2007-06-29
EP0700388B1 (en) 2002-09-18
NO954692L (no) 1995-11-20
AU1849895A (en) 1995-10-17
KR960702442A (ko) 1996-04-27
JPH08511562A (ja) 1996-12-03

Similar Documents

Publication Publication Date Title
TW347386B (en) N-substituted β-aryl- and β-heteroaryl-α-cyanoacrylamide derivatives
HU9502761D0 (en) Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
TW341565B (en) Indole derivatives processes and intermediates for their preparation and pharmaceutical compositions containing them
DE69327541D1 (en) 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
HU9602466D0 (en) Naphthalene derivatives as prostaglandin i2 agonits
CA2327253A1 (en) Sulfonamide-containing indole compounds
TW225513B (zh)
MY109337A (en) Phenoxyl-and phenoxyalkyl-piperidines as antiviral agents
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
MY113266A (en) New indol derivatives derivatives with high affinity 5-ht1a receptor.
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
ZA9510908B (en) Pharmaceutical compounds
TW334428B (en) Novel benzodiazepine derivatives
AU4713697A (en) Process for the preparation of N-(2-(dimethylamino)ethyl)acridine-4-carboxamide
CA2163115A1 (en) N-substituted beta-aryl- and beta-heteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation
TW327636B (en) Heterocyclic ring-fused pyrimidine derivatives
TW349092B (en) Substituted indole derivatives
MX9710530A (es) Derivados de benzo (a) quinolina.